Could an FDA Nod for MR-141 Give Viatris (VTRS) and Opus Genetics (IRD) a Presbyopia Payoff?
insidermonkey.com · 2026-10-08
Viatris Inc. (NASDAQ:VTRS) and Opus Genetics, Inc. (NASDAQ:IRD) are waiting on the same decision.
Read the full story at insidermonkey.com →
Is VTRS undervalued? See TickrTrends' fair value analysis →